Genesis Therapeutics Secures $52M Series A to Further Accelerate AI Innovation and to Launch Drug Discovery & Development Pipeline

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3quPd2v
via IFTTT